Present and future roles of bevacizumab in breast cancer

被引：2
|
作者：
Cortes-Funes, H. [1 ]
机构：
[1] Hosp Univ 12 Octubre, Madrid, Spain
来源：
BREAST CANCER RESEARCH | 2007年 / 9卷 / 01期
关键词：
Vascular Endothelial Growth Factor; Overall Survival; Paclitaxel; Bevacizumab; Docetaxel;
D O I：
10.1186/bcr1705
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] The role of bevacizumab in breast cancer
    Daniele, Gennaro
    Marciano, Roberta
    Tortora, Giampaolo
    EJC SUPPLEMENTS, 2008, 6 (14): : 26 - 29
  • [22] Survival analysis of bevacizumab plus taxane treatment in luminal metastatic breast cancer
    Murillo, Serafin Morales
    Cudos, Ariadna Gasol
    Rodriguez, Joel Veas
    Morales, Carles Canosa
    Olive, Jordi Mele
    Villellas, Felip Vilardell
    Sanchez Guzman, Douglas Rene
    Martinez, Edelmiro Iglesias
    Salvia, Antonieta Salud
    FUTURE SCIENCE OA, 2021, 7 (03):
  • [23] Bevacizumab in the treatment of breast cancer
    Koutras, Angelos K.
    Fountzilas, George
    Makatsoris, Thomas
    Peroukides, Stavros
    Kalofonos, Haralabos P.
    CANCER TREATMENT REVIEWS, 2010, 36 (01) : 75 - 82
  • [24] Bevacizumab in the treatment of breast cancer
    Sirohi, Bhawna
    Smith, Katy
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (10) : 1559 - 1568
  • [25] Salvage therapy of pretreated advanced breast cancer with bevacizumab and paclitaxel every two weeks: a retrospective case review study
    Alexandros Ardavanis
    Dimitrios Doufexis
    Panteleimon Kountourakis
    Savvoula Malliou
    Athanasios Karagiannis
    Evgenia Kardara
    Despina Sykoutri
    Margari Charalampia
    Gerasimos Rigatos
    BMC Cancer, 9
  • [26] Bevacizumab in the treatment of breast cancer: Rationale and current data
    Rugo, HS
    ONCOLOGIST, 2004, 9 : 43 - 49
  • [27] The roles and limitations of bevacizumab in the treatment of ovarian cancer
    Hidekatsu Nakai
    Noriomi Matsumura
    International Journal of Clinical Oncology, 2022, 27 : 1120 - 1126
  • [28] Caution in Adding Bevacizumab in the Adjuvant Treatment of Breast Cancer
    Dimosthenis Ziogas
    Dimitrios Roukos
    Annals of Surgical Oncology, 2010, 17 : 653 - 654
  • [29] Bevacizumab plus Docetaxel and Cisplatin for Metastatic Breast Cancer: A Pilot Phase II Study
    Tai, Cheng-Jeng
    Chen, Ching-Shyang
    Hung, Chin-Sheng
    Kuo, Li-Jen
    Wei, Po-Li
    Chiou, Jeng-Feng
    Hsu, Chung-Huei
    Chiou, Hung-Yi
    Wu, Chih-Hsiung
    ANTICANCER RESEARCH, 2012, 32 (12) : 5501 - 5506
  • [30] Treatment of metastatic breast cancer: looking towards the future
    Amar, Surabhi
    Roy, Vivek
    Perez, Edith A.
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 114 (03) : 413 - 422
12345